UK markets closed

iBio, Inc. (0JV0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.51450.0000 (0.00%)
At close: 09:14AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
-23,162
-65,010
-50,391
-23,207
-16,439
Depreciation & amortisation
1,274
1,380
3,791
2,414
2,241
Stock-based compensation
2,124
4,391
4,377
1,586
388
Change in working capital
-930
5,869
3,243
-11,154
470
Accounts receivable
69
1,000
-886
-426
22
Inventory
0
-1,015
-3,873
772
-798
Accounts payable
-765
-625
1,239
48
498
Other working capital
-19,176
-36,174
-49,110
-35,226
-14,499
Other non-cash items
-285
167
-52
-56
-1
Net cash provided by operating activities
-18,670
-30,436
-37,480
-30,064
-13,345
Cash flows from investing activities
Investments in property, plant and equipment
-
-5,738
-11,630
-5,162
-1,154
Acquisitions, net
0
-692
0
-
-
Purchases of investments
-
0
-7,115
-23,816
0
Sales/maturities of investments
0
10,839
13,618
4,000
0
Other investing activities
-
-
-
-1,500
-
Net cash used for investing activities
1,044
7,009
-5,127
-26,478
-1,154
Cash flows from financing activities
Debt repayment
-1,690
-9,625
-5,830
-331
-2,061
Common stock issued
14,927
11,487
0
-
-
Common stock repurchased
-7
-39
0
-
-
Other financing activities
117
-22
-372
836
-2,170
Net cash used provided by (used for) financing activities
14,242
2,301
-6,125
78,835
65,192
Net change in cash
-3,351
-21,093
-48,732
22,292
50,691
Cash at beginning of period
9,782
28,672
77,404
55,112
4,421
Cash at end of period
6,398
7,579
28,672
77,404
55,112
Free cash flow
Operating cash flow
-18,670
-30,436
-37,480
-30,064
-13,345
Capital expenditure
-
-5,738
-11,630
-5,162
-1,154
Free cash flow
-19,176
-36,174
-49,110
-35,226
-14,499